AGT and cardiac hypertrophy: Thirdly, to determine whether the reduction of VCP under TAC directly resulted from the response of cardiomyocytes or other cell types in the heart, we performed in vitro studies by treating isolated neonatal rat cardiomyocytes (NRCMs) with angiotensin II (AngII), a well‐known stimulator of myocardial hypertrophy.